SLC44A2 (CTL2)

SLC44A2 (CTL2)

<div class="infobox infobox-gene">
<h3>SLC44A2</h3>
<table>
<tr><td><strong>Full Name</strong></td><td>Solute Carrier Family 44 Member 2</td></tr> [@michel2016]
<tr><td><strong>Gene Symbol</strong></td><td>SLC44A2 (CTL2)</td></tr> [@gabr2019]
<tr><td><strong>Chromosomal Location</strong></td><td>9p21.2</td></tr> [@nagai2020]
<tr><td><strong>NCBI Gene ID</strong></td><td>[57103](https://www.ncbi.nlm.nih.gov/gene/57103)</td></tr> [@martinez2021]
<tr><td><strong>OMIM</strong></td><td>[609027](https://omim.org/entry/609027)</td></tr> [@okuda2019]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000137767](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000137767)</td></tr> [@wessler2017]
<tr><td><strong>UniProt</strong></td><td>[Q8WWI5](https://www.uniprot.org/uniprot/Q8WWI5)</td></tr> [@insel2020]
<tr><td><strong>Protein</strong></td><td>Choline transporter-like protein 2 (CTL2)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), platelet disorders, cancer</td></tr>
</table>
</div>

Overview

SLC44A2 (CTL2)

<div class="infobox infobox-gene">
<h3>SLC44A2</h3>
<table>
<tr><td><strong>Full Name</strong></td><td>Solute Carrier Family 44 Member 2</td></tr> [@michel2016]
<tr><td><strong>Gene Symbol</strong></td><td>SLC44A2 (CTL2)</td></tr> [@gabr2019]
<tr><td><strong>Chromosomal Location</strong></td><td>9p21.2</td></tr> [@nagai2020]
<tr><td><strong>NCBI Gene ID</strong></td><td>[57103](https://www.ncbi.nlm.nih.gov/gene/57103)</td></tr> [@martinez2021]
<tr><td><strong>OMIM</strong></td><td>[609027](https://omim.org/entry/609027)</td></tr> [@okuda2019]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000137767](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000137767)</td></tr> [@wessler2017]
<tr><td><strong>UniProt</strong></td><td>[Q8WWI5](https://www.uniprot.org/uniprot/Q8WWI5)</td></tr> [@insel2020]
<tr><td><strong>Protein</strong></td><td>Choline transporter-like protein 2 (CTL2)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), platelet disorders, cancer</td></tr>
</table>
</div>

Overview

SLC44A2 (also known as CTL2, Choline Transporter-Like Protein 2) encodes a member of the Solute Carrier Family 44. SLC44A2 is a membrane transporter that was initially identified as a choline transporter, though its exact physiological substrate and function remain an area of active investigation. The protein is expressed in various tissues including the brain, blood cells, and epithelial tissues. SLC44A2 belongs to the SLC44 family, which includes five members (SLC44A1-5) that share structural features but may have distinct functions. Unlike classical neurotransmitter transporters, SLC44A2 appears to function as a housekeeper transporter involved in maintaining cellular choline homeostasis, which is essential for phosphatidylcholine biosynthesis, acetylcholine synthesis, and membrane integrity. Recent studies have implicated SLC44A2 in platelet function, hearing loss, and potentially in neurodegenerative diseases. This page covers SLC44A2's molecular function, disease associations, expression patterns, and therapeutic implications. [@michel2016][@gabr2019]

Molecular Structure and Mechanism

Protein Domain Architecture

SLC44A2 contains structural features characteristic of the SLC44 family:[@takahashi2020]

Transport Mechanism

SLC44A2 is thought to operate as a secondary transporter:[@okuda2019]

The transport may be coupled to the electrochemical gradient (either Na+ or H+ gradient) though the exact coupling mechanism remains to be fully characterized.

Gene Function

Choline Transport

SLC44A2 participates in choline homeostasis:[@nagai2020][@okuda2019]

• Choline Uptake: SLC44A2 mediates cellular uptake of choline, an essential nutrient.
• Phosphatidylcholine Synthesis: Choline is the precursor for phosphatidylcholine biosynthesis, the most abundant phospholipid in mammalian membranes.
• Acetylcholine Synthesis: Choline is the precursor for acetylcholine, a key neurotransmitter.
• Membrane Maintenance: Choline is required for maintaining membrane integrity and lipid homeostasis.

Lipid Metabolism

SLC44A2 is linked to lipid metabolism:[@suzuki2020][@yamamoto2021]

• Phosphatidylcholine Biosynthesis: Choline transport supports the CDP-choline pathway for phosphatidylcholine synthesis.
• Membrane Biogenesis: Proper phosphatidylcholine levels are essential for membrane synthesis, particularly in neurons with high membrane turnover.
• Lipid Signaling: Choline-derived lipids serve as signaling molecules.

Cellular Functions

SLC44A2 supports various cellular processes:[@hernandez2019]

• Neuronal Function: Choline transport supports acetylcholine synthesis and synaptic function.
• Cell Proliferation: Adequate choline is required for membrane biosynthesis during cell division.
• Cell Survival: Choline deficiency can lead to apoptosis.

Disease Associations

Alzheimer's Disease

Choline transport is relevant to Alzheimer's disease:[@insel2020][@kelley2020]

• Choline Deficiency: AD brains show altered choline metabolism, and reduced choline transport may contribute to this deficit.
• Acetylcholine Loss: AD is associated with cholinergic decline; SLC44A2 may contribute to acetylcholine synthesis capacity.
• Membrane Integrity: Phosphatidylcholine loss is observed in AD; reduced choline transport may contribute.
• Therapeutic Implications: Choline supplementation has been explored as a therapeutic approach; understanding SLC44A2 function may improve targeting.

Parkinson's Disease

Choline dysregulation has been implicated in PD:[@ishii2019]

• Dopaminergic Neurons: Choline metabolism may be altered in dopaminergic neurons.
• Membrane Homeostasis: Proper membrane function is critical for neuronal survival.
• Signal Transduction: Choline-derived signaling molecules may be relevant to PD pathogenesis.

Platelet Disorders

SLC44A2 is highly expressed in blood cells:[@wessler2017][@nahon2019]

• Platelet Activation: SLC44A2 variants have been associated with platelet reactivity.
• Thrombosis Risk: Altered SLC44A2 function may influence thrombosis risk.
• Blood Cell Development: SLC44A2 may function in blood cell development.

Cancer

SLC44A2 expression is altered in some cancers:[@wang2020]

• Tumor Metabolism: Cancer cells often show altered choline metabolism.
• Expression Changes: SLC44A2 expression is modified in various cancer types.
• Therapeutic Target: SLC44A2 may represent a metabolic vulnerability in cancer.

Expression Profile

SLC44A2 shows broad but specific expression:[@chen2020]

Tissue Distribution

• Blood Cells: High expression in platelets and leukocytes.
• Brain: Moderate expression in various brain regions.
• Liver: Expression in hepatocytes.
• Lung: Expression in lung tissue.
• Kidney: Expression in renal tissues.

Cellular Expression

• Neuronal Expression: SLC44A2 is expressed in neurons throughout the brain.
• Glial Expression: Astrocytes and other glial cells express SLC44A2.
• Epithelial Cells: Various epithelial tissues express the transporter.
• Blood Cells: Particularly high expression in megakaryocytes and platelets.

Protein Interactions

SLC44A2 participates in protein interactions:[@tommasino2019]

Transport Complex

• Homomers: SLC44A2 may form homomeric transporters.
• Heteromers: Potential interaction with other SLC44 family members.

Regulatory Proteins

• Kinases: SLC44A2 may be regulated by protein kinases.
• Scaffold Proteins: Interaction with scaffold proteins may target SLC44A2 to specific membrane domains.

Metabolic Enzymes

• Choline Kinases: Downstream enzymes in choline metabolism.
• Acetylcholine Synthesis: Enzymes for acetylcholine production.

Common Variants and Risk Alleles

| Variant | Type | Association | Effect | Ref |
|---------|------|-------------|--------|-----|
| rs2288903 | Missense (P377L) | Platelet reactivity | Altered transport | [@gabr2019] |
| rs4889953 | Intronic | AD risk (suggestive) | Altered expression | - |
| rs10770113 | 3'UTR | Cancer risk (suggestive) | Altered mRNA stability | - |

Therapeutic Implications

Neurodegenerative Disease

SLC44A2 modulation may have therapeutic potential:[@martinez2021][@iwamoto2021]

• Choline Supplementation: Enhancing choline transport may support neuronal function.
• Agonists: Developing SLC44A2-selective agonists to enhance choline uptake.
• Targeted Delivery: Using SLC44A2 for targeted drug delivery.

Cardiovascular Disease

SLC44A2 is relevant to platelet function:[@tommasino2019]

• Antithrombotic Targeting: SLC44A2 inhibitors may reduce platelet activation.
• Bleeding Disorders: Understanding SLC44A2 function may help treat bleeding disorders.

Cancer Therapy

Metabolic targeting may benefit cancer treatment:

• Metabolic Vulnerability: Targeting choline metabolism in cancer cells.
• Combination Therapy: Combining choline transporter targeting with standard therapies.

Animal Models

Mouse Models

• Knockout Studies: Slc44a2 knockout mice show viability and some phenotype.
• Transgenic Models: Overexpression to study disease mechanisms.

In Vitro Models

• Cell Lines: Various cell lines expressing SLC44A2 for study.
• Primary Cells: Neurons, platelets, and other primary cells.

See Also

• [SLC44 Family](/mechanisms/solute-carrier-transport) — Overview of SLC44 transporters
• [Choline Metabolism](/mechanisms/choline-metabolism) — Choline biochemical pathways
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
• [Parkinson's Disease](/diseases/parkinson-disease) — PD overview

External Links

• [NCBI Gene: SLC44A2](https://www.ncbi.nlm.nih.gov/gene/57103)
• [GeneCards: SLC44A2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC44A2)
• [UniProt: Q8WWI5](https://www.uniprot.org/uniprot/Q8WWI5)
• [Ensembl: ENSG00000137767](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000137767)
• [OMIM: 609027](https://omim.org/entry/609027)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving slc44a2 discovered through SciDEX knowledge graph analysis:

Pathway Diagram

The following diagram shows the key molecular relationships involving SLC44A2 (CTL2) discovered through SciDEX knowledge graph analysis: